OPKO Health to Acquire Bio-Reference Laboratories
-
Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy
-
Acquisition provides national sales force to accelerate adoption of OPKO’s 4KscoreTM test for aggressive prostate cancer
MIAMI--- OPKO HEALTH, INC. (OPK) and Bio-Reference Laboratories, Inc. (BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO will acquire Bio-Reference Laboratories. Bio-Reference Laboratories is the third largest full service clinical laboratory in the United States and is known for its innovative technological solutions and pioneering leadership in the areas of genomics and genetic sequencing.
- Published: 04 June 2015
- Written by Editor